The Burrill Personalized Medicine Report, published annually, is designed to keep reader abreast of the latest global developments in this rapidly evolving area. The Report is designed to provide a “snapshot” on a rapidly growing sector and will serve as a reference to the major players and technologies.

Editorial Focus: In the foreseeable future a trip to the doctor’s office will be a radically different experience to what it is today. Armed with our complete genetic profile information about predisposition to disease, the appropriate remedial therapies, even what foods to eat will be part of the doctor’s advice. Welcome to the emerging world of personalized medicine an all-embracing term that covers:

• Predictive Medicine—one of the newest and most exciting developments in medicine today representing a paradigm shift from medicine as the treatment of disease, to medicine as the true prevention of illness.
• Pharmacogenomics—tailoring the right medicine to the right individual at the right time.
• Molecular diagnostics—Scientific advances in genomics and proteomics have led to a new generation of healthcare tools that will enable more effective prediction, diagnosis, characterization, monitoring, and treatment of diseases.
• Biomarkers—Potential biomarker applications extend from drug discovery and development to diagnostic tools.